Gerard Silvestri to Survival Analysis
This is a "connection" page, showing publications Gerard Silvestri has written about Survival Analysis.
Connection Strength
0.250
-
POINT: Is N2 Disease a Contraindication for Surgical Resection for Superior Sulcus Tumors? Yes. Chest. 2015 Dec; 148(6):1373-1375.
Score: 0.114
-
Targeted therapy for the treatment of advanced non-small cell lung cancer: a review of the epidermal growth factor receptor antagonists. Chest. 2005 Dec; 128(6):3975-84.
Score: 0.057
-
First-in-Human Use of a Hybrid Real-Time Ultrasound-Guided Fine-Needle Acquisition System for Peripheral Pulmonary Lesions: A Multicenter Pilot Study. Respiration. 2019; 98(6):527-533.
Score: 0.037
-
High-dose fractionated radiotherapy to 80 Gy for stage I-II medically inoperable non-small-cell lung cancer. J Med Imaging Radiat Oncol. 2010 Dec; 54(6):554-61.
Score: 0.020
-
Underuse of surgical resection for localized, non-small cell lung cancer among whites and African Americans in South Carolina. Ann Thorac Surg. 2008 Jul; 86(1):220-6; discussion 227.
Score: 0.017
-
Prognostic significance of tumor proliferative fraction and DNA content in stage I non-small cell lung cancer. Am Rev Respir Dis. 1992 Sep; 146(3):707-10.
Score: 0.006